Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
03/2000
03/16/2000WO2000014213A1 Highly efficient mutagenesis method with the use of psoralen derivatives
03/16/2000WO2000014212A1 Novel protein kinase molecules and uses therefor
03/16/2000WO2000014209A1 Endothelial cell proliferation inhibitors derived from human prothrombin
03/16/2000WO2000014208A1 Egiii-like cellulase compositions, dna encoding such egiii compositions and methods for obtaining same
03/16/2000WO2000014207A2 Plant farnesyltransferases
03/16/2000WO2000014206A2 Mutant egiii cellulases, dna encoding such egiii compositions and methods for obtaining same
03/16/2000WO2000014205A2 Methods for generating high titer helper-free preparations of released recombinant aav vectors
03/16/2000WO2000014201A1 Polypeptides containing modified, non-natural amino acids and methods of production
03/16/2000WO2000014200A2 Essential bacterial genes and their use
03/16/2000WO2000014115A1 Mc4-r as target for the identification of compounds used to treat drug addiction
03/16/2000WO2000014112A2 Papillomaviruses, means for the detection thereof and therapy for diseases caused thereby
03/16/2000WO2000014106A1 Novel bag proteins and nucleic acid molecules encoding them
03/16/2000WO2000014105A1 Modifications of the vegf receptor-2 protein and methods of use
03/16/2000WO2000014103A1 Stimulation of angiogenesis via enhanced endothelial expression of syndecan-4 core proteins
03/16/2000WO2000014102A1 Photoresponsive nucleosides and phosphoramidites
03/16/2000WO2000013796A1 Capillary printing systems
03/16/2000WO2000013703A2 Methods of treating hypertension and compositions for use therein
03/16/2000WO2000013702A2 Use of an angiogenic factor for the treatment of microvascular angiopathies
03/16/2000WO2000013694A1 Gcp
03/16/2000WO2000013654A2 A carotenoid composition containing phytoene and phytofluene
03/16/2000WO2000013651A2 Luciferase reporter bioassay of parathyroid hormone compounds
03/16/2000WO2000006748A3 Crystallizable farnesyl protein transferase compositions, crystals thereby obtained and methods for use
03/16/2000WO2000006696A3 Method for the modulation of function of transcription factors
03/16/2000WO2000006694A3 Compound and method for the prevention and/or the treatment of allergy
03/16/2000WO2000003038A3 Method and reagents for analyzing the nucleotide sequence of nucleic acids
03/16/2000WO2000003029A3 Chimaeric adenoviruses
03/16/2000WO2000002910A3 Human fast-1 gene
03/16/2000WO2000002897A3 Delta cleavage products and methods based thereon
03/16/2000WO2000000628B1 Replication-defective recombinant adenovirus with mutated major late promoter
03/16/2000WO2000000621A8 Adh7 nucleotides
03/16/2000WO2000000500A3 Polyketides and their synthesis
03/16/2000WO1999067392A3 Modified plant metabolism using pyrophosphate-dependent phosphofructokinase
03/16/2000WO1999067391A9 Origin of replication and methods of use
03/16/2000WO1999065937A9 Truncated apaf-1 and methods of use thereof
03/16/2000WO1999064605A3 Cloning of human choline/ethanolaminephosphotransferases; synthesis of phosphatidylcholine, phosphatidylethanolamine, and platelet activating factor
03/16/2000WO1999064598A3 Novel insulin analogs with enhanced zinc binding
03/16/2000WO1999064592A9 Green fluorescent proteins for measuring the ph of a biological sample
03/16/2000WO1999064579A9 Corn oleosin promoter and genes encoding corn desaturases
03/16/2000WO1999062939A3 Glycoproteins having lipid mobilising properties and therapeutic applications thereof
03/16/2000WO1999062927A9 Connective tissue growth factor-4
03/16/2000WO1999061471A3 Human transmembrane proteins
03/16/2000WO1999060131A3 Hemorrhagic enteritis virus dna sequences, proteins encoded thereby and various uses thereof
03/16/2000WO1999058570A3 Antibodies to the ed-b domain of fibronectin, conjugates containing them and use therefor for diagnosis and therapy of tumors and diseases associated with angiogenesis
03/16/2000WO1999058559B1 Factors affecting tumor necrosis factor receptor releasing enzyme activity
03/16/2000WO1999057151A3 FAP α-SPECIFIC ANTIBODY WITH IMPROVED PRODUCIBILITY
03/16/2000WO1999055906A3 Gene screening methods and related assays
03/16/2000WO1999053064A3 Methods of delivering glp-1
03/16/2000WO1999051723A3 Bacterial transglutaminases
03/16/2000WO1999050404A3 Transgenic animals with inducible protein expression and methods of use
03/16/2000WO1999050403A9 Method and reagents for the treatment of diseases or conditions related to molecules involved in angiogenic responses
03/16/2000WO1999046385A3 Compositions and methods for the treatment and prevention of metastatic disorders
03/16/2000WO1999036516A3 Method of determining the function of nucleotide sequences and the proteins they encode by transfecting the same into a host
03/16/2000DE19853398C1 Identification of 5-methylcytosine positions in genomic DNA by chemical modification, amplification and heteroduplex formation
03/16/2000DE19845434C1 Tissue binding peptides and related nucleotide sequences useful for tissue specific gene transfer
03/16/2000DE19841941A1 A novel metabotropic receptor complex from the central nervous system, related coding sequences and methods of identifying binding substances, ligands and interactions with other proteins
03/16/2000DE19830907A1 Verfahren zur Optimierung der Produktion von Adenovirus-Vektoren A method for optimizing the production of adenovirus vectors
03/16/2000CA2346430A1 Stimulation of angiogenesis via enhanced endothelial expression of syndecan-4 core proteins
03/16/2000CA2343351A1 Human transferase proteins
03/16/2000CA2343156A1 Fusion receptors specific for prostate-specific membrane antigen and uses thereof
03/16/2000CA2342859A1 Production of human erythropoietin
03/16/2000CA2342849A1 Methods for generating high titer helper-free preparations of released recombinant aav vectors
03/16/2000CA2342792A1 Enzymatic oxidative deamination process
03/16/2000CA2342785A1 Capillary printing systems
03/16/2000CA2342393A1 A rapid pcr method for synthesizing dna
03/16/2000CA2342311A1 Novel protein kinase molecules and uses therefor
03/16/2000CA2342284A1 Methylation of plasmid vectors
03/16/2000CA2342124A1 Nucleic acid molecules encoding an amylosucrase
03/16/2000CA2342118A1 Biosensor
03/16/2000CA2342115A1 Nucleic acid molecules encoding enzymes having fructosyltransferase activity, and their use
03/16/2000CA2342070A1 Grf analogs with increased biological potency
03/16/2000CA2342027A1 Novel bag proteins and nucleic acid molecules encoding them
03/16/2000CA2341782A1 Methods and compositions for modulating the interaction between the apj receptor and the hiv virus
03/16/2000CA2341778A1 Method for amplifying all dna fragments in a sample
03/16/2000CA2341777A1 Neutral amino acid transporter and gene thereof
03/16/2000CA2341762A1 Highly efficient mutagenesis method with the use of psoralen derivatives
03/16/2000CA2341760A1 17 kda foam protein
03/16/2000CA2341349A1 Attenuated cells comprising sp12 mutants, carriers and compositions containing same, methods of production and uses thereof
03/16/2000CA2341338A1 G-motif oligonucleotides and uses thereof
03/16/2000CA2341327A1 Novel protein and dna thereof
03/16/2000CA2341326A1 Novel protein and process for producing the same
03/16/2000CA2341325A1 Method of stimulating prosaposin receptor activity
03/16/2000CA2341314A1 Method for studying protein interactions in vivo
03/16/2000CA2341307A1 Antibody for detecting possibility of onset of bovine leukemia
03/16/2000CA2341302A1 Lim domain protein homolog
03/16/2000CA2341156A1 Method for selecting peptides inhibiting viral surface protein binding to cell surface receptor
03/16/2000CA2341154A1 Novel receptor protein and method for the diagnosis of an inflammatory disease by using the same
03/16/2000CA2341149A1 Hypertension associated transcription factor-1 (hatf-1) and hatf related protein 1 (hrp-1)
03/16/2000CA2340686A1 Novel molecules of the herpes virus-entry-mediator-related protein family and uses thereof
03/16/2000CA2340598A1 Modifications of the vegf receptor-2 protein and methods of use
03/16/2000CA2340581A1 Phenolic acid esterases, coding sequences and methods
03/16/2000CA2340361A1 Assays using crosslinkable immobilized nucleic acids
03/16/2000CA2340331A1 Mutant egiii cellulases, dna encoding such egiii compositions and methods for obtaining same
03/16/2000CA2340323A1 Mc4-r as target for the identification of compounds used to treat drug addiction
03/16/2000CA2309212A1 Essential bacterial genes and their use
03/15/2000EP0985732A2 Trimeric chimera protein and collagen matrix containing chimera protein
03/15/2000EP0985731A1 MUTATED $g(a)-AMYLASES
03/15/2000EP0985730A1 Method for cloning and producing the snaBI restriction endonuclease and purification thereof
03/15/2000EP0985729A2 Streptokinase mutants
03/15/2000EP0985149A1 Methods for evaluating tissue morphogenesis and activity
03/15/2000EP0985053A1 Translational frameshift based drug screening assay
1 ... 3271 3272 3273 3274 3275 3276 3277 3278 3279 3280 3281 3282 3283 3284 3285 3286 3287 3288 3289 3290 3291 ... 4023